Work

Phase II trial of biologically optimized schedule of gemcitabine and nab-paclitaxel in metastatic pancreatic cancer.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.e16325

Authors: Anne M. Noonan, Anne M. Noonan, Laith I. Abushahin, Lai Wei, Pannaga G. Malalur, Ashish Manne, Arjun Mittra, Sameek Roychowdhury, Ning Jin, John L. Hays, Melissa A. Babcook, Zachary Risch, Shafia Rahman, Brooke Hazard, Terence Marques Williams

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Baylor University Medical Center, The Ohio State University Wexner Medical Center, City Of Hope National Medical Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400414165

Cites:

Cited by: 1

Related to: 10